Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know.
Camila Lopes VendramiMichael J MagnettaPardeep K MittalCourtney C MorenoFrank H MillerPublished in: Radiographics : a review publication of the Radiological Society of North America, Inc (2020)
Gallbladder carcinoma is the most common cancer of the biliary system. It is challenging to diagnose because patients are often asymptomatic or present with nonspecific symptoms that mimic common benign diseases. Surgical excision is the only curative therapy and is best accomplished at early non-locally advanced stages. Unfortunately, gallbladder cancer often manifests at late locally advanced stages, precluding cure. Early tumors are often incidentally detected at imaging or at cholecystectomy performed for another indication. Typical imaging features of localized disease include asymmetric gallbladder wall thickening, polyps larger than 1.0 cm, and a solid mass replacing the gallbladder lumen. Advanced tumors are often infiltrative and can be confusing at CT and MRI owing to their large size. Determination of the origin of the lesion is paramount to narrow the differential diagnosis but is often challenging. It is important to identify gallbladder cancer and distinguish it from other benign and malignant hepatobiliary processes. Since surgical resection is the only curative treatment option, radiologist understanding and interpretation of pathways of nodal and infiltrative tumor spread can direct surgery or preclude patients who may not benefit from surgery. While both CT and MRI are effective, MRI provides superior soft-tissue characterization of the gallbladder and biliary tree and is a useful imaging tool for diagnosis, staging, and evaluation of treatment response. ©RSNA, 2020.
Keyphrases
- contrast enhanced
- papillary thyroid
- magnetic resonance imaging
- locally advanced
- rectal cancer
- high resolution
- computed tomography
- neoadjuvant chemotherapy
- minimally invasive
- squamous cell
- end stage renal disease
- squamous cell carcinoma
- magnetic resonance
- prognostic factors
- lymph node
- chronic kidney disease
- coronary artery bypass
- radiation therapy
- soft tissue
- stem cells
- coronary artery disease
- positron emission tomography
- image quality
- artificial intelligence
- newly diagnosed
- lymph node metastasis
- depressive symptoms
- atrial fibrillation
- young adults
- peritoneal dialysis
- mass spectrometry
- combination therapy
- percutaneous coronary intervention
- smoking cessation
- surgical site infection
- fluorescence imaging
- mesenchymal stem cells
- study protocol
- tandem mass spectrometry